Difference between revisions of "International Alliance of Patient Organisations"
| Line 1: | Line 1: | ||
The Guardian reports: | The Guardian reports: | ||
| − | :IAPO was set up in 1999 by 38 patient groups with funds from the Pharmaceutical Partners for Better Healthcare, a collaboration of some 40 drug companies. Pharmaceutical Partners closed down that same year, throwing IAPO into serious financial difficulties. Pfizer stepped in with a grant in 2002 to help IAPO develop a strategy for the future. A variety of individual companies have supported it since then. In 2006, drug companies contributed $250,554 (£127,000) out of a total income of $278,755. In 2006, GSK, Pfizer, Medtronic and Novartis were the biggest sponsors, each providing more than $50,000 a year. | + | :IAPO was set up in 1999 by 38 patient groups with funds from the Pharmaceutical Partners for Better Healthcare, a collaboration of some 40 drug companies. Pharmaceutical Partners closed down that same year, throwing IAPO into serious financial difficulties. Pfizer stepped in with a grant in 2002 to help IAPO develop a strategy for the future. A variety of individual companies have supported it since then. In 2006, drug companies contributed $250,554 (£127,000) out of a total income of $278,755. In 2006, GSK, Pfizer, Medtronic and Novartis were the biggest sponsors, each providing more than $50,000 a year.<ref>Sarah Boseley, health editor [http://www.guardian.co.uk/medicine/story/0,,2084179,00.html Drug firms and patient groups join in fight to overturn advertising ban] Monday May 21, 2007 The Guardian </ref> |
| − | <ref>Sarah Boseley, health editor [http://www.guardian.co.uk/medicine/story/0,,2084179,00.html Drug firms and patient groups join in fight to overturn advertising ban] Monday May 21, 2007 The Guardian </ref> | ||
==Notes== | ==Notes== | ||
<references/> | <references/> | ||
| + | [[Category:Patient Groups]] | ||
Latest revision as of 08:01, 22 October 2007
The Guardian reports:
- IAPO was set up in 1999 by 38 patient groups with funds from the Pharmaceutical Partners for Better Healthcare, a collaboration of some 40 drug companies. Pharmaceutical Partners closed down that same year, throwing IAPO into serious financial difficulties. Pfizer stepped in with a grant in 2002 to help IAPO develop a strategy for the future. A variety of individual companies have supported it since then. In 2006, drug companies contributed $250,554 (£127,000) out of a total income of $278,755. In 2006, GSK, Pfizer, Medtronic and Novartis were the biggest sponsors, each providing more than $50,000 a year.[1]
Notes
- ↑ Sarah Boseley, health editor Drug firms and patient groups join in fight to overturn advertising ban Monday May 21, 2007 The Guardian
